Table 1.
Laboratory data of case 1
| Case 1 | Reference range, adult | 5 days after onset | 8 days after onset | 12 days after onset |
|---|---|---|---|---|
| Hematocrit (%) | 35.0–48.0 | 37.3 | 40.9 | 28.5 |
| Hemoglobin (g/dl) | 12.0–16.0 | 12.9 | 14.3 | 9.8 |
| White-cell count (/μL) | 4500–8500 | 2200 | 5460 | 13180 |
| Platelet count (×104/μL) | 13.0–32.0 | 5.6 | 4.1 | 5.0 |
| Lymphocyte count (/μL) | 1000–4000 | 315 | ||
| Neutrophil count (/μL) | 1000–7500 | 1232 | ||
| Aspartate aminotransferase (IU/L) | 13–33 | 679 | 3210 | 323 |
| Alanine aminotransferase (IU/L) | 6–30 | 290 | 1073 | 282 |
| Lactate dehydrogenase (IU/L) | 119–229 | 972 | 2736 | 648 |
| Creatine phosphokinase (IU/L) | 45–163 | 4414 | 5926 | 304 |
| Creatinine (mg/dl) | 0.4-0.7 | 1.4 | 1.42 | 2.94 |
| C-reactive protein (mg/dl) | <0.3 | 0.4 | 0.52 | 4.94 |
| Prothrombin time (%) | 70–120 | 61.4 | 100 | |
| Activated partial thromboplastin time (seconds) | 26.1–35.6 | 64.1 | 35.1 | |
| Fibrinogen (mg/dl) | 150–450 | 142 | 407 | |
| Antithrombin III (mg/dl) | 80–120 | 124 | ||
| Fibrin/fibrinogen degradation products (μg/ml) | <5.0 | 14.0 | 4.7 | |
| D dimer (μg/ml) | <1.0 | 5.4 | 0.8 | |
| (1-3)-β-D glucan (pg/ml) | <3.8 | 261.7 |